Doctors & patients are saying about 'A-Fib.com'...


"A-Fib.com is a great web site for patients, that is unequaled by anything else out there."

Dr. Douglas L. Packer, MD, FHRS, Mayo Clinic, Rochester, MN

"Jill and I put you and your work in our prayers every night. What you do to help people through this [A-Fib] process is really incredible."

Jill and Steve Douglas, East Troy, WI 

“I really appreciate all the information on your website as it allows me to be a better informed patient and to know what questions to ask my EP. 

Faye Spencer, Boise, ID, April 2017

“I think your site has helped a lot of patients.”

Dr. Hugh G. Calkins, MD  Johns Hopkins,
Baltimore, MD


Doctors & patients are saying about 'Beat Your A-Fib'...


"If I had [your book] 10 years ago, it would have saved me 8 years of hell.”

Roy Salmon, Patient, A-Fib Free,
Adelaide, Australia

"This book is incredibly complete and easy-to-understand for anybody. I certainly recommend it for patients who want to know more about atrial fibrillation than what they will learn from doctors...."

Pierre Jaïs, M.D. Professor of Cardiology, Haut-Lévêque Hospital, Bordeaux, France

"Dear Steve, I saw a patient this morning with your book [in hand] and highlights throughout. She loves it and finds it very useful to help her in dealing with atrial fibrillation."

Dr. Wilber Su,
Cavanaugh Heart Center, 
Phoenix, AZ

"...masterful. You managed to combine an encyclopedic compilation of information with the simplicity of presentation that enhances the delivery of the information to the reader. This is not an easy thing to do, but you have been very, very successful at it."

Ira David Levin, heart patient, 
Rome, Italy

"Within the pages of Beat Your A-Fib, Dr. Steve Ryan, PhD, provides a comprehensive guide for persons seeking to find a cure for their Atrial Fibrillation."

Walter Kerwin, MD, Cedars-Sinai Medical Center, Los Angeles, CA


Catheter Ablation For Atrial Fibrillation (Pulmonary Vein Ablation/Isolation)

Catheter ablation of the pulmonary veins

Catheter ablation of the pulmonary veins.

Today catheter ablation is considered a first-line strategy choice in patients with Atrial Fibrillation and is vastly superior to using antiarrhythmic drugs first to treat Atrial Fibrillation symptoms.

A catheter ablation is performed by applying concentrated amounts of energy to small, targeted areas of heart tissues to destroy the tissue and create minute amounts of scar tissue known as a lesion. The lesion creates an barrier that stops the irregular electric signal, effectively stopping A-Fib from occurring.

Early catheter ablations (known then as Focal Ablation) were first performed in 1994 in Bordeaux, France (where I was cured of my Atrial Fibrillation in 1998). Over the past few decades, the technology has continued to evolve with rapid development of new techniques.

Worldwide, it’s estimated over 1.4 million cardiac catheter ablation procedures were performed in 2024 with Atrial fibrillation representing the largest and fastest-growing share of these treatments. The number of procedures is growing about 6%–8% a year.

Atrial Fibrillation: Best Technique for a Cure

Being “cured” of A-Fib is defined as restoring patients to “normal sinus rhythm” without dependence on any medications.

As a point of reference, the National Cancer Society considers someone “cured” of cancer if they are in remission for 5 years.

A catheter ablation, and specifically a Pulmonary Vein Ablation (PVA), is currently the best technique available for “curing” A-Fib. It is currently the only minimally invasive treatment for A-Fib which offers hope of a cure.

Pulmonary Vein Ablation techniques are achieving success rates of 70%-85% in making Paroxysmal A-Fib patients A-Fib free. With a second ablation, for Persistent A-Fib, for example, the success rates rise to over 90%.

Ablation Benefits Even If Not Cured: The other 15%-30% of catheter ablation patients, though not “cured” of A-Fib, may be significantly improved after an ablation. They may have fewer or less intense attacks of A-Fib. Medications that didn’t work before may now control the A-Fib. (But for some there may not be any noticeable improvement at all.)

VIDEO: What is Catheter Ablation? (click image to watch)

What is Catheter Ablation? Dr. Darryl Wells explains two ways catheter ablation is used to eliminate the triggers of A-Fib and how 3-dimensional mapping assists the physicians in viewing the anatomy and electric system of the heart. (2:33) By Swedish Heart & Vascular Institute. (Or, Watch on YouTube)

For more videos visit our Library of A-Fib Videos including:

When Drug Therapy Fails: Why Patients Consider Catheter Ablation (3:00), and Catheter Ablation For A-Fib: What it is, How it’s Done and What Results Can Be Expected (4:00).

Catheter Ablation Procedure

Catheter inserted into the heart and through septum wall into Left Atria

Catheter inserted into the heart and through septum wall into Left Atria.

During a catheter ablation, the heart is beating and in constant motion (unlike open-heart surgeries when a heart-lung machine temporarily takes over the work of the heart and lungs).

A soft, thin, flexible, coated tube with an electrode at the tip is inserted through a large vein in your groin and moved into your heart. (The catheter is about the width of the lead in a pencil, while the vein is about the size of your little finger.)

These catheters can be inserted in both your right and left groins, and sometimes in your neck as well (for monitoring).

Catheter ablation is a relatively painless procedure, because there are no nerve endings in the smooth tissue of the heart and veins.

3D Imaging to Detect A-Fib Signals

Electrophysiologists (EPs) use Fluoroscopy, a special type of X-Ray, along with imaging systems to see inside the heart.

Sensors on specialized mapping catheters record electrical activity from multiple heart walls at once. Computer software builds a digital 3D model of your heart’s anatomy which highlights the chaotic electrical signals.

3D images of heart with inset image of sensor tip of catheter.

3D images of heart with inset image of sensor tip of catheter.

Location and Isolation of Atrial Fibrillation Signals

Research has shown that most A-Fib signals come from the openings (ostia) or sleeves of the four Pulmonary Veins in the left atrium.

Energy Sources: Today’s catheter devices differ by their energy source: heat (Radio Frequency), freezing (CryoBalloon) and electrical pulses (Pulsed Field Ablation).

Illustration: A left atrial pulmonary vein ostium and sleeve.

RF Energy Ablation Lesions: One technique is to make circular radiofrequency (RF) ablation lines around each pulmonary vein opening. This isolates the pulmonary veins (PVs) from the rest of the heart and prevents any pulses from these veins from getting into the heart.

Or, EPs may make one large oval lesion encircling and isolating two PVs at the same time (called Wide Area Antrum Circumferential Isolation).

Cryo Energy Ablation Lesions: Another technique to form a circular ablation uses a balloon catheter and cryo (freezing) energy to encircle the vein opening and make the circular lesions.

3D Ablation Map: White dots are RF lesions. Notice the continuous line formed.

3D Ablation Map of heart: White dots are RF lesions. Notice the continuous line formed.

Note: Timing of your ablation is more important than the energy source used. Getting an ablation within the first 12 months after diagnosis improves outcomes, i.e., before significant remodeling can alter your heart.

Locating More A-Fib Signals: Pulmonary Vein Potentials

A different method of locating and eliminating A-Fib signals uses Pulmonary Vein Potentials. A potential is an electrical charge or energy—like the battery energy in your car. Even if your car isn’t running, you can still measure 12 volts “potential” at the battery.

Similarly, in your heart any potential in a pulmonary vein area can be measured and pinpointed, even if you aren’t in A-Fib at the time. When the area is ablated, the potential disappears.

The Final Check: Induce A-Fib/Flutter with Drugs

As a final check after the Pulmonary Vein potentials or PV triggers are isolated, the EP will try to induce A-Fib (or Flutter) by the use of drugs such as Isoproterenol or Adenosine. (Hopefully, A-Fib will not recur.) All too often other A-Fib potentials or trigger sites are found outside of the Pulmonary Veins.

These have to be tracked down, mapped, and ablated/isolated. Sometimes potentials or other areas of abnormal electrical activity are not visible during the procedure because the pulmonary vein triggers suppress or hide them. That’s why many EPs wait a half hour before proceeding to allow these potentials or possible gaps to appear.

The goal is to eliminate all these sites so that A-Fib (Flutter) can no longer be induced.

Ablation for Persistent A-Fib/Recurrent A-Fib: Looking Beyond the PVs

While it’s generally accepted that most cases of Atrial Fibrillation are triggered from inside or close to the Pulmonary Veins, alas this is not the case for many patients with Persistent A-Fib. The same is true with cases of Very Late Recurrence Atrial Fibrillation (A-Fib that recurs 5-10 or more years later after a successful catheter ablation.)

My own A-Fib returned 20 years after I was cured in 1998 in Bordeaux, France. You can read about my 2019-2021 ablations (including a Watchman) and the multiple locations of my non-PV triggers that were ablated…I have been A-Fib free since.  

In 12%-20% of cases, A-Fib triggers for Persistent A-Fib and Very Late Recurrence A-Fib are found outside the pulmonary veins.

Possible locations of non–pulmonary vein triggers for atrial fibrillation

After a catheter ablation of the Pulmonary Veins, if A-Fib persists, a repeat ablation procedure will first look for and ablate any gaps in the lesions around the PVs (the heart is a resilient muscle that tries to heal the lesions). Then, the EP will seek out and ablate non-pulmonary vein triggers.

Major sources of non-pulmonary vein triggers in other areas of the heart are:

• left atrial posterior wall
• left atrial appendage
• ligament of Marshall
• coronary sinus
• superior vena cava
• crista terminalis

This type of “investigative” ablation requires a “master” electrophysiologist, someone with the experience to track down all possible sources of A-Fib signals. (For a list of these EPs, see Steve’s Directory of Doctors: Doctors Specializing in Persistent/Long-standing Persistent A-Fib.)

Types of Catheter Ablations: How They Differ

Three types of catheter ablations are available: Radiofrequency Ablation, CryoAblation and Pulsed Field Ablation.

Radiofrequency Ablation

Illustration: Radiofrequency catheter delivering RF energy.

Early Radiofrequency (RF) Ablations date back to 1994. RF Ablation is a well-established minimally-invasive cardiac procedure with decades of use to treat A-Fib.

RF Ablation uses radiofrequency energy delivered through a catheter with an electrode. The catheter applies radiofrequency waves directly to the tissue, creating a burn that destroys cells through coagulative necrosis. The catheter is highly maneuverable, allowing for precise point-by-point ablation.

RF Ablation of the Pulmonary Veins: A thin catheter is guided into the heart, then a 3D map of the heart is created. To isolate the Pulmonary Veins, RF energy is used in a point-by-point approach to form a continuous scar line. The catheter must be precisely maneuvered to apply heat around each pulmonary vein, making it time-consuming but offering more control in complex cases.

RF Ablation provides flexibility to create customized lesions beyond the pulmonary veins. It allows for highly customized scar patterns—ideal for complex cases including Persistent Atrial Fibrillation.

Complications: severe risks are uncommon; they include Atrioesophageal Fistula and Phrenic Nerve injury.

CyroAblation

CryoBalloon catheter

Illustration: CryoBalloon catheter at PV

CryoAblation was approved for A-Fib use in December 2010. Cryoablation is best suited for simpler A-Fib cases, as its balloon shape limits lesion flexibility. It works well for Pulmonary Vein isolation but is less adaptable for targeting other areas.

CryoAblation of the Pulmonary Veins: A tiny balloon at the tip of the catheter is inflated at the opening of the Pulmonary Veins. The balloon shapes to the tissue, creating a steady, uniform circular block in a single application. Cold coolant gas chills the balloon, freezing and disabling the surrounding tissue to form a continuous scar line.

With Cryoballoon catheters, EPs can temporarily cool tissue to check placement (with an option to reverse) before freezing it permanently. Unlike RF ablation “burns” that can crust, fall off and lead to a blood clot (that’s why blood thinners like heparin are used to avoid this), with CryoAblation tissue freezing this doesn’t happen. There is less risk of damaging other areas of the heart or esophagus. Generally, procedure times are shorter than RF ablations.

The main complication of CryoAblation is a temporary palsy of the phrenic nerve.

CyroAblation/RF Ablation Combined for Persistent A-Fib: Some centers first use Cryoballoon catheters to isolate the Pulmonary Veins with uniform, circular lesions, then use RF catheters (or non-balloon Cryo catheters) to make linear lesions to target other areas of the heart.

Pulsed Field Ablation

Illustration: PFA catheter from FARAPULSE™ in flower mode.

Pulsed Field Ablation is widely approved and used in Europe beginning in 2021. U.S. trials began in 2019 with FDA approval in 2024. There are five FDA-approved Pulsed Field Ablation systems (with differing catheter configurations).

What makes it different? Pulsed Field Ablation uses a fundamentally different process to ablate heart tissue. An instantaneous electrical field (irreversible electroporation) is applied and the cell dies (there is no charring or crust formation) and the cell remains intact. PFA makes a long-lasting lesion in a matter of seconds vs RF and Cryo (60 seconds–150 seconds per lesion).

Pulsed Field Ablation of Pulmonary Veins and Other Areas
A typical Pulsed Field Ablation, for example, using the FARAPULSE™ PFA System involves positioning the unique catheter with electrodes convertible from a “basket” configuration, then a “flower” configuration.

Each Pulmonary Vein opening receives paired energy deliveries, first with the “basket” configuration, then with the “flower” configuration. Then they are rotated, for a total of eight applications per vein to complete and ensure electric field penetration.

The same technique can be used in other areas of the heart, i.e., ablating the Posterior Wall of the Left Atrium. Or, in the right atrium, for example, making a Cavo-Tricuspid Isthmus line to ablate Flutter.

The PFA process is “tissue selective” meaning the signal doesn’t affect other surrounding non-heart tissue such as the esophagus or phrenic nerve making PFA much safer than other ablation energy sources.

Procedural times are usually 1–3 hours for PFA versus 3–5 hours for RF and Cryo Catheter Ablations.

For a full description of PFA, see Pulsed Field Ablation—Groundbreaking Innovation in Atrial Fibrillation!

Summary: Types of Catheter Ablation

Radiofrequency Ablation and CryoAblation each offer unique benefits and limitations when treating Atrial Fibrillation. These differences influence the choice of method based on patient needs and case complexity.

Pulmonary Vein Ablation is a low risk procedure but it is not risk free. For more, see Risks Associated with Pulmonary Vein Procedure.
Together they have established catheter ablation as an effective and durable treatment for Atrial Fibrillation supported by randomized clinical trials and long-term clinical experience. Comprehensive head-to-head clinical trials show that overall success rates between CryoAblation and RF Ablation are highly comparable for Paroxysmal A-Fib.

Both reliably achieve Pulmonary Vein isolation. Complications for both involve the non-selective nature of injury from thermal energies (RF and Cyro).

Pulsed Field Ablation introduces a fundamentally different approach based on irreversible electroporation enabling rapid lesion formation with relative protection of surrounding tissues. Contemporary randomized trials demonstrate results comparable to Radiofrequency and CryoAblation, along with effectiveness and a favorable safety profile.

As a relatively new procedure, Pulsed Field Ablation will continue to evolve alongside the established thermal techniques of Radiofrequency Ablation and CryoAblation.

Permanently A-Fib Free?

Catheter Ablation is currently the only minimally-invasive strategy offering the hope of becoming A-Fib free permanently. (The various Maze surgeries successfully treat A-Fib but are usually done concurrent with other open-heart surgeries.)

Recurrence predictors…the importance of early treatment with catheter ablation rather than later. 

Other factors can influence whether you stay A-Fib free after a “successful” catheter ablation.

Early Treatment: Research from the Mayo Clinic shows that having an ablation within one year of your initial A-Fib diagnosis significantly cuts down the risk of your A-Fib returning.

Lifestyle Changes: Addressing obesity, smoking, lack of exercise and alcohol intake will help keep the heart in a normal rhythm long-term. For more, see my article about Lifestyle Choices and What You Can Do.

Managing Comorbidities: Most A-Fib patients have at least one concurrent medical condition (e.g., hypertension, diabetes, sleep apnea) that makes treating A-Fib more difficult and can have a direct effect on maintenance of normal sinus rhythm after a catheter ablation. For more, see my article about Comorbid Risks.

Recurrence: A “successful” ablation though, may not be permanent. The problem is called recurrence (or reconduction). Heart tissue is very hardy. Over time ablation scars can heal over and allow A-Fib signals to again disrupt the heart.

But other factors strongly influence if your A-Fib recurs. Recurrence is influenced by an enlarged heart, development of fibrosis and progression to Persistent A-Fib or Long-Standing Persistent A-Fib.

All these predictors are influenced by how long and how far your A-Fib has progressed. This underlines the importance of early treatment with catheter ablation rather than later.

If recurrence occurs, a “touch-up” catheter ablation can increase your odds of a cure by up to 90% (see my A-Fib story for my recurrence after 20 years and my return to a life free of A-Fib).

Find the Best EP for Your type of A-Fib

The success of your catheter ablation often depends on the skill, techniques, and experience of the electrophysiologist (EP.)

Choose an EP and A-Fib center that do a high volume of catheter ablations with a high success rate.
That’s why you want to choose an EP and A-Fib center that do a high volume of catheter ablations with a high success rate.

Don’t just go to an EP because they are near you. Go to the best you can find and reasonably afford to travel to.

To find the right doctor and electrophysiologist for you and your treatment goals, go to our page, Finding the Right Doctor for You and Your A-Fib.

Since catheter ablation has become a first-line strategy choice for Atrial Fibrillation, the number of heart centers in the U.S. performing catheter ablations for A-Fib has steadily grown (the number of international centers has increased as well.)

For help finding EPs treating Atrial Fibrillation patients, see Steve’s Directory of Doctors Treating A-Fib: Medical Centers and Practices.

For surgical options for treating Atrial Fibrillation, see The Cox-Maze & Mini-Maze Surgeries and the Hybrid Surgery/Ablation.

If you find any errors on this page, email us. Y  Last updated: Monday, August 31, 2026

Return to Treatments for Atrial Fibrillation

Back to the Top    

References
• Joglar, J. A. et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. Volume 149, Number 1. 30 November 2023. https://doi.org/10.1161/CIR.0000000000001193

Cushing J, et al. Recurrence of Atrial Fibrillation/Flutter Over Long-Term Follow-Up After Index Atrial Fibrillation Catheter Ablation. J Cardiovasc Electrophysiol. 2026 Mar;37(3):593-605. doi: 10.1111/jce.70231. Epub 2026 Jan 21. PMID: 41566140.

• AlTurki A, et al. Targeting nonpulmonary vein triggers during atrial fibrillation ablation: is the game worth the candle? Curr Opin Cardiol. 2018 Jan;33(1):50-57. doi: 10.1097/HCO.0000000000000469. PMID: 29135523.

• Amin AM, et al. Impact of diagnosis to ablation time on recurrence of atrial fibrillation and clinical outcomes after catheter ablation: A systematic review and meta-analysis with reconstructed time-to-event data. Circulation: Arrhythmia and Electrophysiology. 2025;18:170. https://doi.org/10.1161/CIRCEP.124.01326

• Haïssaguerre M. “Electrophysiological End Point for Catheter Ablation of Atrial Fibrillation Initiated From Multiple Pulmonary Venous Foci,” Circulation. 2000;101:p. 1409\

• Heath JR, Han S, Alzahrani A, Hamon D, Powers EM, Conti S, Farjo PD, Dominic P. Early vs delayed ablation for new-onset atrial fibrillation: 5-Year real-world data outcomes. Heart Rhythm O2. 2025 Nov 4;6(12):1886-1892. doi: 10.1016/j.hroo.2025.09.019. PMID: 41541733; PMCID: PMC12800836.

• Turagam MK, et al. Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation: A Meta-analysis of Randomized Clinical Trials. JAMA Cardiol. 2021 Jun 1;6(6):697-705. doi: 10.1001/jamacardio.2021.0852. PMID: 33909022; PMCID: PMC8082432.

• Cardiac Ablation Catheters Market. ResearchandMarkets.com/Reports. Overview. ID: 5357350. 121 Pages. May 2021. Accessed August 21, 2026. https://tinyurl.com/CardiacAblationCathetersMarket

• The Evolving Cardiac Ablation Market: New Technologies, New Opportunities/Life Science Market Research. Feb 23, 2025. https://www.lifesciencemarketresearch.com/insights/the-evolving-cardiac-ablation-market-new-technologies-new-opportunities

• Atrial Fibrillation Educational Material,” University of Pennsylvania, 2001, p.7 “Catheter ablation is a low-risk procedure”

• Jais, P. “Ablation Therapy for Atrial Fibrillation: Past, Present and Future,” Cardiovascular Research, Vol. 54, Issue 2, May 2002, P. 343

• Jaïs, P. NASPE Convention presentation, San Diego, CA, May 8, 2002

• Cappato R et al. “Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.” Circulation: Arrhythmia and Electrophysiology. 2010: 3:32-38. “When analyzed in a large number of electrophysiology laboratories worldwide, catheter ablation of AF shows to be effective in approximately 80% of patients after 1.3 procedures per patient, with approximately 70% of them not requiring further antiarrhythmic drugs during intermediate follow-up.”

• “Catheter ablation can successfully cure AF (A-Fib) in up to 80% of patients and reduce mortality by more than 50%.” “Over time, AF (A-Fib) is also associated with an increased risk of death.” Atrial Fibrillation Association “Information Toolkit” CD, Atrial Fibrillation Patient Information.

• Haissaguerre, M, Gencel L, Fischer B, Le Metayer P, Poquet F, Marcus FI, Clementy J. Successful catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (1994)5:1045–1052.

• Hassaguerre M et al. “Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.” New England Journal of Medicine. 1998;339;659-666.

• Chen, SA et al. “Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation. 1999;100:1879-1886.

• Jaïs, P. NASPE Convention presentation, San Diego, CA, May 8, 2002.

• In the opinion of the author, the best technique currently available for curing paroxysmal AF (assuming it originates from the pulmonary veins) is segmental isolation of the pulmonary veins by discrete applications of radiofrequency energy at the ostia, guided by pulmonary vein potentials.” Scheinman M. “Nonpharmacological Approaches to Atrial Fibrillation,” Circulation. 2001:103: p. 2120.

• Prystowsky E. “Management of Atrial Fibrillation: Therapeutic Options and Clinical Decisions,”  The American Journal of Cardiology. Vol. 85 (10A), May 25, 2000, p. 5D.

• Olsson S. “Atrial fibrillation – where do we stand today?”  Journal of Internal Medicine. 2001;250: p. 19.21Haïssaguerre M. “Successful Catheter Ablation of Atrial Fibrillation,” Journal of Cardiovascular Electrophysiology 5 (1994), pp. 1045-1052.

• Natale A. “First Human Experience With Pulmonary Vein Isolation Using a Through-the-Balloon Circumferential Ultrasound Ablation System for Recurrent Atrial Fibrillation,” Circulation. 2000;102:pp.1879-1882.

• Haïssaguerre M. “Electrophysiological End Point for Catheter Ablation of Atrial Fibrillation Initiated From Multiple Pulmonary Venous Foci,” Circulation. 2000;101:p. 1409.

• Jais, P. “Ablation Therapy for Atrial Fibrillation: Past, Present and Future,” Cardiovascular Research, Vol. 54, Issue 2, May 2002, P. 343.

• Jaïs, P. NASPE Convention presentation, San Diego, CA, May 8, 2002.

• Pappone, Carlo et al. “Circumferential Pulmonary Vein Ablation for Atrial Fibrillation: the Milan Experience,” Cardiac Electrophysiology and Pacing Unit of the Department of Cardiology, San Raffaele University Hospital, Milan, Italy. 2003. p. 7. “…the term “electroanatomical remodeling” coined by us derives from the fact that circumferential PV ablation, when effective, determines a significant reduction in LA size and improvement in its transport function during follow-up”.

• Boston A-Fib Symposium presentation, January 17, 2004.

• “Atrial Fibrillation Educational Material,” University of Pennsylvania, 2001, p.7 “Catheter ablation is a low-risk procedure”.

Related Posts

Follow Us
facebook - A-Fib.comtwitter - A-Fib.comlinkedin - A-Fib.compinterest - A-Fib.comYouTube: A-Fib Can be Cured! - A-Fib.com

We Need You Help A-Fib.com be self-supporting-Use our link to Amazon  

A-Fib.com is a
501(c)(3) Nonprofit



Your support is needed. Every donation helps, even just $1.00.


Home | The A-Fib Coach | Help Support A-Fib.com | A-Fib News Archive | Tell Us What You think | Press Room | Candid Seal | HON certification | Disclosures | Terms of Use | Privacy Policy